Filing Flows › AbbVie (ABBV) › Q2 2026
AbbVie (ABBV) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 3, 2026
AbbVie (ABBV) reported revenue of $17.0B for the second quarter 2026 (Q2 2026), +10% from a year earlier and +13% from the quarter before. Operating margin was 37.9%, net earnings $3.6B (21.3% of revenue).
AbbVie, Q2 2026: revenue $17.0B (+10% year over year), operating margin 37.9%, net earnings $3.6B, operating cash flow $3.4B. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $17.0B | +13% | +10% |
| Operating profit | $6.4B | +61% | +31% |
| Net earnings | $3.6B | +419% | +284% |
| Operating cash flow | $3.4B | -10% | -33% |
| Free cash flow | $3.1B | -13% | -36% |
What changed
Revenue was $17.0B in Q2 2026, up 10% year over year and up 13% from the previous quarter.
Operating profit was $6.4B, a 37.9% margin (up 6.1 points year over year). Of the extra revenue versus Q2 2025, 98% reached operating profit, above the 32% margin then. Total costs grew 0% against revenue growth of 10%. The fastest-growing cost line was SG&A (+12%). Net earnings were $3.6B, up 285% year over year. The effective tax rate was 15.5%.
Operating cash flow was $3.4B (down 33% year over year), 95% of net earnings. Non-cash charges added back $1.9B of depreciation and amortization and $0.17B of share-based compensation. Working capital and other items used $2.2B. Capital expenditures of $0.32B left free cash flow of $3.1B.
Questions
What was AbbVie's revenue in the second quarter 2026?
AbbVie (ABBV) reported revenue of $17.0B for the second quarter 2026 (Q2 2026), +10% from a year earlier and +13% from the quarter before.
Was AbbVie profitable in the second quarter 2026?
Operating profit was $6.4B (37.9% of revenue) and net earnings $3.6B.
Source: AbbVie 10-Q on SEC EDGAR.